Influenza virus vaccine - GC Biopharma
Alternative Names: GC3102CLatest Information Update: 01 Apr 2022
At a glance
- Originator Green Cross
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 29 Mar 2022 GC Pharma is now called GC Biopharma
- 08 Jul 2013 Green Cross Corporation completes a phase III trial in Influenza virus infections prevention in Vietnam (NCT01750814)
- 30 Jun 2013 Phase-III clinical trials in Influenza virus infections prevention in Vietnam (IM)